Previous 10 | Next 10 |
2024-03-26 16:36:29 ET More on Stoke Therapeutics Stoke stock rockets 73% on updated epilepsy drug data TD Cowen ups Stoke to buy on updated data for epilepsy drug Seeking Alpha’s Quant Rating on Stoke Therapeutics Historical earnings data for Stoke Th...
A look at the top 10 most actives in the United States C3is Inc. (CISS) rose 36.6% to $0.0481 on volume of 589,492,515 shares Nikola Corporation (NKLA) rose 9.5% to $0.8139 on volume of 120,009,646 shares Tesla Inc. (TSLA) rose 2.9% to $177.67 on volume of 112,332,335 shares Direxion Da...
2024-03-26 12:55:48 ET More on Mid-day movers & stocks. Veritone: Not An AI Stock To Bank On Veritone, Inc. (VERI) Q4 2023 Earnings Call Transcript Check-Cap jumps on Nobul AI business combination Veritone Non-GAAP EPS of -$0.16 in-line, revenue of $34.2M...
Stoke Therapeutics, Inc. (NASDAQ: STOK) is one of today's top gainers. The company's shares have moved 59.23% on the day to $10.35. Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of sev...
2024-03-26 10:29:11 ET More on Stoke Therapeutics TD Cowen ups Stoke to buy on updated data for epilepsy drug Stoke stock soars 70% post-market on epilepsy drug data Seeking Alpha’s Quant Rating on Stoke Therapeutics Historical earnings data for Stoke ...
2024-03-26 10:01:57 ET More on Stoke Therapeutics Stoke stock soars 70% post-market on epilepsy drug data Seeking Alpha’s Quant Rating on Stoke Therapeutics Historical earnings data for Stoke Therapeutics Financial information for Stoke Therapeutics ...
A look at the top 10 most actives in the United States C3is Inc. (CISS) rose 50.9% to $0.0531 on volume of 188,520,681 shares OpGen Inc. (OPGN) rose 64.8% to $0.783 on volume of 46,448,042 shares KULR Technology Group Inc. (KULR) rose 26.2% to $0.4102 on volume of 30,163,025 shares Tesl...
2024-03-26 09:00:03 ET Joseph Stringer from Needham issued a price target of $22.00 for STOK on 2024-03-26 07:10:00. The adjusted price target was set to $22.00. At the time of the announcement, STOK was trading at $6.5. The overall price target consensus is at $41.50 wi...
2024-03-26 05:23:14 ET More on related stocks Westport Fuel Systems: Q4 Earnings Review And Update MicroStrategy: A Bad Deal For Investors MicroStrategy: Too Far, Too Fast Stoke stock soars 70% post-market on epilepsy drug data MicroStrategy buys 9,24...
2024-03-25 18:02:21 ET More on Stoke Therapeutics Stoke stock soars 70% post-market on epilepsy drug data Seeking Alpha’s Quant Rating on Stoke Therapeutics Historical earnings data for Stoke Therapeutics Read the full article on Seeking Alpha ...
News, Short Squeeze, Breakout and More Instantly...
Stoke Therapeutics Inc. Company Name:
STOK Stock Symbol:
NYSE Market:
2024-06-16 20:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced that management will present at the following upcoming investor conferences: Goldma...
2024-05-16 08:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...